Title | Type | SJR | H index | Total Docs. (2020) | Total Docs. (3years) | Total Refs. (2020) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2020) | %Female (2020) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.955 Q1 | 103 | 78 | 283 | 11625 | 2008 | 257 | 6.61 | 149.04 | 44.61 | |
2 | Current Cancer Drug Targets | journal | 0.972 Q1 | 103 | 75 | 237 | 5949 | 734 | 219 | 3.13 | 79.32 | 38.95 | |
3 | Current Medicinal Chemistry | journal | 0.934 Q1 | 202 | 382 | 1048 | 47291 | 4223 | 959 | 3.80 | 123.80 | 47.17 | |
4 | CNS and Neurological Disorders - Drug Targets | journal | 0.923 Q2 | 96 | 65 | 287 | 5920 | 1076 | 265 | 3.94 | 91.08 | 39.63 | |
5 | Journal of Toxicology | journal | 0.829 Q2 | 47 | 35 | 78 | 1600 | 383 | 77 | 5.22 | 45.71 | 36.31 | |
6 | Current Drug Targets | journal | 0.826 Q2 | 119 | 141 | 450 | 15650 | 1540 | 422 | 3.15 | 110.99 | 40.00 | |
7 | Current Vascular Pharmacology | journal | 0.806 Q2 | 69 | 76 | 225 | 5973 | 643 | 197 | 2.27 | 78.59 | 30.77 | |
8 | Current Molecular Pharmacology | journal | 0.717 Q2 | 49 | 32 | 89 | 2336 | 258 | 81 | 3.21 | 73.00 | 44.76 | |
9 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.710 Q2 | 52 | 26 | 89 | 2460 | 300 | 85 | 3.84 | 94.62 | 33.94 | |
10 | Current Topics in Medicinal Chemistry | journal | 0.706 Q2 | 133 | 240 | 735 | 21755 | 2287 | 620 | 2.65 | 90.65 | 44.44 | |
11 | International Journal of Genomics | journal | 0.705 Q2 | 37 | 62 | 223 | 3036 | 598 | 217 | 2.38 | 48.97 | 39.89 | |
12 | Current Gene Therapy | journal | 0.704 Q2 | 80 | 38 | 129 | 2994 | 406 | 113 | 3.25 | 78.79 | 44.16 | |
13 | Current Pharmaceutical Design | journal | 0.690 Q2 | 183 | 515 | 1637 | 53255 | 5006 | 1517 | 2.78 | 103.41 | 43.76 | |
14 | Mini-Reviews in Medicinal Chemistry | journal | 0.603 Q2 | 107 | 149 | 359 | 14217 | 1277 | 339 | 3.65 | 95.42 | 42.91 | |
15 | Current Radiopharmaceuticals | journal | 0.586 Q3 | 32 | 23 | 92 | 922 | 228 | 84 | 3.09 | 40.09 | 37.50 | |
16 | Current Clinical Pharmacology | journal | 0.565 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
17 | Reviews on Recent Clinical Trials | journal | 0.509 Q3 | 35 | 44 | 130 | 1929 | 200 | 115 | 1.47 | 43.84 | 32.78 | |
18 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.508 Q3 | 108 | 231 | 590 | 14800 | 1433 | 572 | 2.31 | 64.07 | 41.05 | |
19 | Current Drug Delivery | journal | 0.449 Q2 | 72 | 76 | 320 | 5298 | 764 | 303 | 2.63 | 69.71 | 42.09 | |
20 | Current Drug Safety | journal | 0.334 Q3 | 41 | 36 | 117 | 1064 | 177 | 114 | 1.79 | 29.56 | 40.52 | |
21 | Medicinal Chemistry | journal | 0.308 Q3 | 50 | 92 | 242 | 4815 | 575 | 238 | 2.29 | 52.34 | 44.69 | |
22 | Combinatorial Chemistry and High Throughput Screening | journal | 0.292 Q3 | 70 | 109 | 272 | 4931 | 367 | 251 | 1.15 | 45.24 | 41.28 | |
23 | Current Nanoscience | journal | 0.285 Q3 | 52 | 88 | 212 | 6490 | 351 | 203 | 1.74 | 73.75 | 33.14 | |
24 | Current Computer-Aided Drug Design | journal | 0.226 Q4 | 32 | 73 | 111 | 3171 | 129 | 99 | 1.36 | 43.44 | 36.29 | |
25 | Letters in Drug Design and Discovery | journal | 0.223 Q3 | 37 | 144 | 426 | 5796 | 461 | 413 | 1.11 | 40.25 | 38.05 | |
26 | Current Pharmaceutical Analysis | journal | 0.210 Q3 | 27 | 137 | 241 | 5109 | 206 | 239 | 0.86 | 37.29 | 44.26 | |
27 | Current Drug Therapy | journal | 0.174 Q3 | 20 | 53 | 51 | 3296 | 31 | 49 | 0.54 | 62.19 | 41.27 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®